Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 4/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 8/20 | 0.81 |
| ▸ | CYP1A2 | P05177 | 7/20 | 0.81 |
| ▸ | HTR1A | P08908 | 6/20 | 0.81 |
| ▸ | TP53 | P04637 | 5/20 | 0.81 |
| ▸ | CHRM2 | P08172 | 5/20 | 0.81 |
| ▸ | ADRA2A | P08913 | 5/20 | 0.81 |
| ▸ | CHRM1 | P11229 | 5/20 | 0.81 |
| ▸ | DRD1 | P21728 | 5/20 | 0.81 |
| ▸ | SLC6A2 | P23975 | 5/20 | 0.81 |
| ▸ | SLC6A4 | P31645 | 5/20 | 0.81 |
| ▸ | ADRA1A | P35348 | 5/20 | 0.81 |
| ▸ | OPRM1 | P35372 | 5/20 | 0.81 |
| ▸ | DRD3 | P35462 | 5/20 | 0.81 |
| ▸ | KCNH2 | Q12809 | 5/20 | 0.81 |
| ▸ | DRD2 | P14416 | 4/20 | 0.81 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.81 |
| ▸ | SIGMAR1 | Q99720 | 4/20 | 0.81 |
| ▸ | THPO | P40225 | 3/20 | 0.81 |
| ▸ | MTOR | P42345 | 3/20 | 0.81 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fenethazine SCHEMBL29394568 | 1.00 | KDM1A (1.00) | KDM1ACYP2D6CYP1A2HTR1ATP53 | |
| Fenethazine SCHEMBL662746 | 0.98 | KDM1A (0.96) | KDM1ACYP2D6CYP1A2HTR1ATP53 | |
| Promazine SCHEMBL9052694 | 0.89 | CYP2D6 (1.00) | KDM1ACYP2D6CYP1A2HTR1ATP53 | |
| Promazine SCHEMBL29392545 | 0.89 | CYP2D6 (1.00) | KDM1ACYP2D6CYP1A2HTR1ATP53 | |
| Promazine SCHEMBL140489 | 0.89 | CYP2D6 (1.00) | KDM1ACYP2D6CYP1A2HTR1ATP53 | |
| Promazine SCHEMBL123418 | 0.88 | LMNA (1.00) | KDM1ACYP2D6CYP1A2HTR1ATP53 | |
| Promazine SCHEMBL29390978 | 0.88 | LMNA (1.00) | KDM1ACYP2D6CYP1A2HTR1ATP53 | |
| SCHEMBL6865346 | 0.88 | CYP2D6 (0.90) | KDM1ACYP2D6CYP1A2HTR1ATP53 | |
| Promazine SCHEMBL27429489 | 0.88 | CYP2D6 (0.97) | KDM1ACYP2D6CYP1A2HTR1ATP53 | |
| Promazine SCHEMBL27425063 | 0.88 | CYP2D6 (0.97) | KDM1ACYP2D6CYP1A2HTR1ATP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 413 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118993872-A | Refining process of fendithiino tussah acid | 四川吉龙兴瑞药业有限公司 | 2024-11-22 | — | — | CN | claimed |
| CN-117535168-A | Bacillus megaterium ZLP-21 and application thereof | 河北省科学院生物研究所 | 2024-02-09 | — | — | CN | claimed |
| US-9016221-B2 | Surface topographies for non-toxic bioadhesion control | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2015-04-28 | — | — | US | claimed |
| US-20110212173-A1 | Controlled Release Treatment of Depression | e-Therapeutics Ple (GB) | 2011-09-01 | — | — | US | claimed |
| EP-2315585-A1 | CONTROLLED RELEASE TREATMENT OF DEPRESSION | E-Therapeutics plc (GB) | 2011-05-04 | — | — | EP | claimed |
| US-20100226943-A1 | SURFACE TOPOGRAPHIES FOR NON-TOXIC BIOADHESION CONTROL | UNIVERSITY OF FLORIDA (US) | 2010-09-09 | — | — | US | claimed |
| CN-101801361-A | Treatment of depression | THERAPEUTICS LTD E | 2010-08-11 | — | — | CN | claimed |
| WO-2010004256-A1 | CONTROLLED RELEASE TREATMENT OF DEPRESSION | E-THERAPEUTICS PLC (GB) | 2010-01-14 | — | — | WO | claimed |
| EP-2014282-A2 | Treatment of depression | E-Therapeutics plc (GB) | 2009-01-14 | — | — | EP | claimed |
| US-20090005443-A1 | Treatment of Depression | E-THERAPEUTICS LIMITED (GB) | 2009-01-01 | — | — | US | claimed |
| WO-2009001040-A2 | TREATMENT OF DEPRESSION | E-THERAPEUTICS PLC (GB) | 2008-12-31 | — | — | WO | claimed |
| CN-101330905-A | Freeze-drying process and products obtained thereby | SCIDOSE LLC (US) | 2008-12-24 | — | — | CN | claimed |
| EP-1954244-A1 | LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY | Scidose, Llc (US) | 2008-08-13 | — | — | EP | claimed |
| WO-2007061529-A1 | LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY | SCIDOSE LLC. (US) | 2007-05-31 | — | — | WO | claimed |
| US-20070116729-A1 | Lyophilization process and products obtained thereby | SCIDOSE LLC | 2007-05-24 | — | — | US | claimed |
| WO-2005094832-A1 | COMPOSITIONS COMPRISING MELOXICAM | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2005-10-13 | — | — | WO | claimed |
| EP-1336602-A1 | Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases | Scaramuzzino, Giovanni (IT) | 2003-08-20 | — | — | EP | claimed |
| EP-0599943-A1 | LEUKOTRIENE RECEPTOR ANTAGONIST-ANTIHISTAMINE COMPLEX | ALLERGAN, INC. (US) | 1994-06-08 | — | — | EP | claimed |
| WO-1993003723-A1 | LEUKOTRIENE RECEPTOR ANTAGONIST-ANTIHISTAMINE COMPLEX | ALLERGAN, INC. (US) | 1993-03-04 | — | — | WO | claimed |
| US-20260134941-A1 | BIOINFORMATIC PROCESSES FOR DETERMINATION OF PEPTIDE BINDING | IOGENETICS LLC (US) | 2026-05-14 | — | — | US | disclosed |
| EP-4692178-A1 | CELLULOSE POWDER AND MOLDED BODY | Asahi Kasei Kabushiki Kaisha (JP) | 2026-02-11 | — | — | EP | disclosed |
| US-12374421-B2 | Bioinformatic processes for determination of peptide binding | IOGENETICS, LLC (US) | 2025-07-29 | — | — | US | disclosed |
| WO-2025121315-A1 | CELLULOSE POWDER AND MOLDED BODY | 旭化成株式会社 | 2025-06-12 | — | — | WO | disclosed |
| CN-118546816-B | Bacillus bailii and application thereof | 贵州大学 | 2025-04-11 | — | — | CN | disclosed |
| CN-119530052-A | Brevibacillus laterosporus and application thereof | 中国农业科学院蜜蜂研究所 | 2025-02-28 | — | — | CN | disclosed |
| CN-119307411-A | Bacillus bailii and separation method and application thereof | 山东省烟台市农业科学研究院(山东省农业科学院烟台市分院) | 2025-01-14 | — | — | CN | disclosed |
| CN-119307400-A | Salt-tolerant bacillus and application thereof | 中国农业科学院蜜蜂研究所 | 2025-01-14 | — | — | CN | disclosed |
| CN-119220433-A | Bacillus pumilus and application thereof | 中国农业科学院蜜蜂研究所 | 2024-12-31 | — | — | CN | disclosed |
| CN-119144490-A | Bacillus amyloliquefaciens and application thereof | 中国农业科学院蜜蜂研究所 | 2024-12-17 | — | — | CN | disclosed |
| WO-2024204699-A1 | CELLULOSE POWDER AND MOLDED BODY | 旭化成株式会社 | 2024-10-03 | — | — | WO | disclosed |
| CN-118546816-A | Bacillus bailii and application thereof | 贵州大学 | 2024-08-27 | — | — | CN | disclosed |
| CN-118384290-A | Hybrid immunoglobulins containing non-peptide linkages | 生物分子控股有限责任公司 | 2024-07-26 | — | — | CN | disclosed |
| CN-117511760-B | Bacillus polymyxa ZLP-61 and application thereof | 河北省科学院生物研究所 | 2024-07-05 | — | — | CN | disclosed |
| CN-117535169-B | Bacillus licheniformis ZLP-81 and application thereof | 河北省科学院生物研究所 | 2024-06-11 | — | — | CN | disclosed |
| CN-117535169-A | Bacillus licheniformis ZLP-81 and application thereof | 河北省科学院生物研究所 | 2024-02-09 | — | — | CN | disclosed |
| CN-117511760-A | Bacillus polymyxa ZLP-61 and application thereof | 河北省科学院生物研究所 | 2024-02-06 | — | — | CN | disclosed |
| CN-115011503-B | Bacillus bailii microbial inoculum for biological control of tobacco double black disease and application thereof | 陕西嘉益蓝德生物工程有限公司 | 2024-01-19 | — | — | CN | disclosed |
| CN-116490778-A | Compositions and methods for preventing, inhibiting, disrupting or treating a multi-microbial biofilm | 国家儿童医院研究所 | 2023-07-25 | — | — | CN | disclosed |
| CN-116217277-A | Organic biogas slurry fertilizer and preparation method thereof | 南京农丰生物科技有限公司 | 2023-06-06 | — | — | CN | disclosed |
| EP-3385306-B1 | COMPOSITE PARTICLES INCLUDING CELLULOSE, INORGANIC COMPOUND, AND HYDROXYPROPYL CELLULOSE | ASAHI CHEMICAL IND (JP) | 2023-01-25 | — | — | EP | disclosed |
| US-20220313656-A1 | NEW CLASS OF ANTIBIOTICS HAVING LOW MIC-VALUES TOWARDS DIFFERENT STRAINS OF BACTERIA | Københavns Universitet (DK) | 2022-10-06 | — | — | US | disclosed |
| US-20220047505-A1 | Controlled Absorption Water-Soluble Pharmaceutically Active Organic Compound Formulation for Once-Daily Administration | STI PHARMA, LLC (US) | 2022-02-17 | — | — | US | disclosed |
| US-11191719-B2 | Controlled absorption water-soluble pharmaceutically active organic compound formulation for once-daily administration | STI PHARMA, LLC (US) | 2021-12-07 | — | — | US | disclosed |
| US-10869933-B2 | Oligomer-phenothiazine conjugates | NEKTAR THERAPEUTICS (US) | 2020-12-22 | — | — | US | disclosed |
| WO-2020216777-A1 | NEW CLASS OF ANTIBIOTICS HAVING LOW MIC-VALUES TOWARDS DIFFERENT STRAINS OF BACTERIA | Københavns Universitet (DK) | 2020-10-29 | — | — | WO | disclosed |
| EP-1712583-B1 | POROUS CELLULOSE AGGREGATE AND FORMED PRODUCT COMPOSITION COMPRISING THE SAME | ASAHI CHEMICAL IND (JP) | 2020-09-16 | — | — | EP | disclosed |
| US-20200197310-A1 | Technology for Preparation of Macromolecular Microspheres | NEXBIO, INC. | 2020-06-25 | — | — | US | disclosed |
| US-10583086-B2 | Technology for preparation of macromolecular microspheres | ANSUN BIOPHARMA, INC. (US) | 2020-03-10 | — | — | US | disclosed |
| US-20200038517-A1 | OLIGOMER-PHENOTHIAZINE CONJUGATES | NEKTAR THERAPEUTICS (US) | 2020-02-06 | — | — | US | disclosed |
| US-10463611-B2 | Controlled absorption water-soluble pharmaceutically active organic compound formulation for once-daily administration | STI PHARMA, LLC (US) | 2019-11-05 | — | — | US | disclosed |
| CN-110392680-A | Substituted azolyl pyrrolidones and azolyl hydantoins and salts thereof and their use as herbicidal active substances | 拜耳作物科学股份公司 | 2019-10-29 | — | — | CN | disclosed |
| US-10426838-B2 | Composite particles including cellulose, inorganic compound, and hydroxypropyl cellulose | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2019-10-01 | — | — | US | disclosed |
| EP-2291233-B1 | METHOD FOR DRY GRANULATION | ATACAMA LABS OY (FI) | 2019-09-04 | — | — | EP | disclosed |
| CN-106458860-B | Pesticidal compositions and methods related thereto | 美国陶氏益农公司 | 2019-07-26 | — | — | CN | disclosed |
| CN-106165684-B | Pesticidal compositions and methods relating thereto | 陶氏益农公司 | 2019-06-14 | — | — | CN | disclosed |
| US-10265272-B2 | Method and apparatus for dry granulation | ATACAMA LABS OY (FI) | 2019-04-23 | — | — | US | disclosed |
| US-10231938-B2 | Transdermal drug delivery device including an occlusive backing | NOVEN PHARMACEUTICALS, INC. (US) | 2019-03-19 | — | — | US | disclosed |
| EP-2254558-B1 | ORALLY DISINTEGRATING TABLETS WITH SPECKLED APPEARANCE | ALPEX PHARMA SA (CH) | 2019-03-13 | — | — | EP | disclosed |
| CN-105732580-B | Pesticidal compositions and methods related thereto | 陶氏益农公司 | 2018-12-07 | — | — | CN | disclosed |
| CN-105025715-B | Pesticidal compositions and methods related thereto | 美国陶氏益农公司 | 2018-11-16 | — | — | CN | disclosed |
| US-20180326063-A1 | COMPOSITE PARTICLES INCLUDING CELLULOSE, INORGANIC COMPOUND, AND HYDROXYPROPYL CELLULOSE | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2018-11-15 | — | — | US | disclosed |
| CN-108739826-A | Rice shoot field herbicidal and preparation method thereof | 芜湖福民生物药业股份有限公司 | 2018-11-06 | — | — | CN | disclosed |
| EP-2081669-B1 | PROCESS AND APPARATUS FOR FOR PRODUCING GRANULES | ATACAMA LABS OY (FI) | 2018-10-17 | — | — | EP | disclosed |
| EP-3385306-A1 | COMPOSITE PARTICLES INCLUDING CELLULOSE, INORGANIC COMPOUND, AND HYDROXYPROPYL CELLULOSE | Asahi Kasei Kabushiki Kaisha (JP) | 2018-10-10 | — | — | EP | disclosed |
| EP-2391386-B1 | OLIGOMER-PHENOTHIAZINE CONJUGATES | NEKTAR THERAPEUTICS (US) | 2018-06-27 | — | — | EP | disclosed |
| CN-104981160-B | Pesticidal compositions and methods related thereto | 美国陶氏益农公司 | 2018-04-20 | — | — | CN | disclosed |
| US-20180071219-A1 | Technology for Preparation of Macromolecular Microspheres | NEXBIO, INC. | 2018-03-15 | — | — | US | disclosed |
| US-20180028449-A1 | Technology for the Preparation of Microparticles | NEXBIO, INC. | 2018-02-01 | — | — | US | disclosed |
| CN-104981154-B | Pesticidal compositions and methods related thereto | 美国陶氏益农公司 | 2018-01-26 | — | — | CN | disclosed |
| EP-2285355-B1 | PROCESS FOR PREPARING A HIGH DRUG LOAD TABLET | ATACAMA LABS OY (FI) | 2018-01-24 | — | — | EP | disclosed |
| US-20170281470-A1 | METHOD AND APPARATUS FOR DRY GRANULATION | ATACAMA LABS OY (FI) | 2017-10-05 | — | — | US | disclosed |
| US-9737386-B2 | Dosage projectile for remotely treating an animal | SMARTVET PTY LTD (AU) | 2017-08-22 | — | — | US | disclosed |
| EP-2285354-B1 | PROCESS FOR PREPARING A LOW DRUG LOAD TABLET | ATACAMA LABS OY (FI) | 2017-07-19 | — | — | EP | disclosed |
| US-9700513-B2 | Method and apparatus for dry granulation | ATACAMA LABS OY (FI) | 2017-07-11 | — | — | US | disclosed |
| CN-104378986-B | Pesticidal compositions and methods related thereto | 陶氏益农公司 | 2017-05-31 | — | — | CN | disclosed |
| US-20170079920-A1 | Technology for the Preparation of Microparticles | NEXBIO, INC. | 2017-03-23 | — | — | US | disclosed |
| CN-106458860-A | Pesticidal compositions and methods related thereto | 美国陶氏益农公司 | 2017-02-22 | — | — | CN | disclosed |
| CN-106455569-A | Use of 3-isoxazolidinone compounds as selective herbicides | FMC有限公司 | 2017-02-22 | — | — | CN | disclosed |
| CN-103826452-B | Pesticidal compositions and processes related thereto | 陶氏益农公司 | 2017-02-01 | — | — | CN | disclosed |
| CN-103281901-B | Pesticidal compositions and methods related thereto | 陶氏益农公司 | 2016-12-28 | — | — | CN | disclosed |
| US-9494572-B2 | Method and compositions for treating cancer and related methods | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) | 2016-11-15 | — | — | US | disclosed |
| CN-106102463-A | Low foaming agrochemical composition | 科莱恩国际有限公司 | 2016-11-09 | — | — | CN | disclosed |
| US-9446137-B2 | Composite particles which contain both cellulose and inorganic compound | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2016-09-20 | — | — | US | disclosed |
| US-20160235675-A1 | Technology for the Preparation of Microparticles | NEXBIO, INC. | 2016-08-18 | — | — | US | disclosed |
| EP-1807033-B1 | TRANSDERMAL DRUG DELIVERY DEVICE INCLUDING AN OCCLUSIVE BACKING | NOVEN PHARMA (US) | 2016-07-20 | — | — | EP | disclosed |
| US-20160128949-A1 | TRANSDERMAL DRUG DELIVERY DEVICE INCLUDING AN OCCLUSIVE BACKING | NOVEN PHARMACEUTICALS, INC. (US) | 2016-05-12 | — | — | US | disclosed |
| US-20160132631-A1 | BIOINFORMATIC PROCESSES FOR DETERMINATION OF PEPTIDE BINDING | IOGENETICS, LLC | 2016-05-12 | — | — | US | disclosed |
| US-20160081782-A1 | Dosage Projectile for Remotely Treating an Animal | SMARTVET PTY LTD (AU) | 2016-03-24 | — | — | US | disclosed |
| EP-2287234-B1 | CELLULOSE POWDER HAVING EXCELLENT SEGREGATION PREVENTIVE EFFECT, AND COMPOSITIONS THEREOF | ASAHI KASEI CHEMICALS CORP (JP) | 2016-03-23 | — | — | EP | disclosed |
| EP-2994115-A1 | DOSAGE PROJECTILE FOR REMOTELY TREATING AN ANIMAL | Smartvet Pty Ltd (AU) | 2016-03-16 | — | — | EP | disclosed |
| US-9238001-B2 | Delivery system for remote treatment of an animal | SMARTVET PTY LTD. (AU) | 2016-01-19 | — | — | US | disclosed |
| US-20160008777-A1 | PHARMACEUTICAL COMPOUNDING KIT | NOVOTEC CONSULTING, LLC | 2016-01-14 | — | — | US | disclosed |
| WO-2016007617-A2 | PHARMACEUTICAL COMPOUNDING KIT | NOVOTEC CONSULTING, LLC. (US) | 2016-01-14 | — | — | WO | disclosed |
| EP-2589618-B1 | COMPOSITE PARTICLES WHICH CONTAIN BOTH CELLULOSE AND INORGANIC COMPOUND | ASAHI KASEI CHEMICALS CORP (JP) | 2015-12-30 | — | — | EP | disclosed |
| US-20150359746-A1 | Technology for the Preparation of Microparticles | NEXBIO, INC. | 2015-12-17 | — | — | US | disclosed |
| US-20150290134-A1 | TECHNOLOGY FOR PREPARATION OF MACROMOLECULAR MICROSPHERES | NEXBIO, INC. | 2015-10-15 | — | — | US | disclosed |
| US-9155712-B2 | Transdermal drug delivery device including an occlusive backing | NOVEN PHARMACEUTICALS, INC. (US) | 2015-10-13 | — | — | US | disclosed |
| US-9132195-B2 | Cellulose powder having excellent segregation preventive effect, and compositions thereof | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2015-09-15 | — | — | US | disclosed |
| US-9134297-B2 | Method and compositions for treating cancer and related methods | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) | 2015-09-15 | — | — | US | disclosed |
| US-20150238427-A1 | METHOD AND APPARATUS FOR DRY GRANULATION | ATACAMA LABS OY (FI) | 2015-08-27 | — | — | US | disclosed |
| US-20150224101-A1 | Method and Compositions for Treating Cancer and Related Methods | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 2015-08-13 | — | — | US | disclosed |
| CN-104758253-A | Technology for preparation of macromolecular microspheres | NEXBIO INC | 2015-07-08 | — | — | CN | disclosed |
| US-20150174255-A1 | COMPOSITE PARTICLES WHICH CONTAIN BOTH CELLULOSE AND INORGANIC COMPOUND | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2015-06-25 | — | — | US | disclosed |
| US-20150157578-A1 | TRANSDERMAL DRUG DELIVERY DEVICE INCLUDING AN OCCLUSIVE BACKING | NOVEN PHARMACEUTICALS, INC. (US) | 2015-06-11 | — | — | US | disclosed |
| US-9016221-B2 | Surface topographies for non-toxic bioadhesion control | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2015-04-28 | — | — | US | disclosed |
| US-20150093438-A1 | Tramadol for Treating Depression | E-THERAPEUTICS PLC (GB) | 2015-04-02 | — | — | US | disclosed |
| EP-2846786-A1 | TRAMADOL FOR TREATING DEPRESSION | e-Therapeutics plc (GB) | 2015-03-18 | — | — | EP | disclosed |
| US-8968788-B2 | Granules, tablets and granulation | ATACAMA LABS OY (FI) | 2015-03-03 | — | — | US | disclosed |
| US-20150050713-A1 | Technology for the Preparation of Microparticles | NEXBIO, INC. | 2015-02-19 | — | — | US | disclosed |
| US-8951636-B2 | Composite particles which contain both cellulose and inorganic compound | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2015-02-10 | — | — | US | disclosed |
| US-8951562-B2 | Method and apparatus or dry granulation | ATACAMA LABS OY (FI) | 2015-02-10 | — | — | US | disclosed |
| WO-2014200910-A2 | BIOINFORMATIC PROCESSES FOR DETERMINATION OF PEPTIDE BINDING | IOGENETICS, LLC (US) | 2014-12-18 | — | — | WO | disclosed |
| US-20140341815-A1 | DELIVERY SYSTEM FOR REMOTE TREATMENT OF AN ANIMAL | SMARTVET PTY LTD. (AU) | 2014-11-20 | — | — | US | disclosed |
| WO-2014179831-A1 | DOSAGE PROJECTILE FOR REMOTELY TREATING AN ANIMAL | SMARTVET PTY LTD (AU) | 2014-11-13 | — | — | WO | disclosed |
| CN-104119333-A | Guanfu alcohol-amine derivatives as well as preparation method and medical use thereof | LIU JINGHAN | 2014-10-29 | — | — | CN | disclosed |
| US-8815281-B2 | Transdermal drug delivery device including an occlusive backing | NOVEN PHARMACEUTICALS, INC. (US) | 2014-08-26 | — | — | US | disclosed |
| US-8802135-B2 | Delivery system for remote treatment of an animal | SMARTVET PTY LTD. (AU) | 2014-08-12 | — | — | US | disclosed |
| US-20140154313-A1 | Controlled Absorption Water-Soluble Pharmaceutically Active Organic Compound Formulation for Once-Daily Administration | STI PHARMA, LLC (US) | 2014-06-05 | — | — | US | disclosed |
| US-20140134150-A1 | TECHNOLOGY FOR PREPARATION OF MACROMOLECULAR MICROSPHERES | ANSUN BIOPHARMA, INC. (US) | 2014-05-15 | — | — | US | disclosed |
| CN-103784408-A | Technology for the preparation of microparticles | ANSUN BIOPHARMA INC | 2014-05-14 | — | — | CN | disclosed |
| EP-2717860-A1 | CONTROLLED ABSORPTION WATER-SOLUBLE PHARMACEUTICALLY ACTIVE ORGANIC COMPOUND FORMULATION FOR ONCE-DAILY ADMINISTRATION | STI Pharma, LLC (US) | 2014-04-16 | — | — | EP | disclosed |
| US-20140099696-A1 | Technology for the Preparation of Microparticles | ANSUN BIOPHARMA, INC. (US) | 2014-04-10 | — | — | US | disclosed |
| US-8623419-B2 | Technology for preparation of macromolecular microspheres | ANSUN BIOPHARMA, INC. (US) | 2014-01-07 | — | — | US | disclosed |
| US-8597686-B2 | Porous cellulose aggregate and formed product composition comprising the same | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2013-12-03 | — | — | US | disclosed |
| US-8591941-B2 | Transdermal drug delivery device including an occlusive backing | NOVEN PHARMACEUTICALS, INC. (US) | 2013-11-26 | — | — | US | disclosed |
| US-8581134-B2 | Method and apparatus for dry granulation | ATACAMA LABS OY (FI) | 2013-11-12 | — | — | US | disclosed |
| US-20130296437-A1 | Treatment of Depression | E-THERAPEUTICS PLC (GB) | 2013-11-07 | — | — | US | disclosed |
| WO-2013164561-A1 | TRAMADOL FOR TREATING DEPRESSION | E-THERAPEUTICS PLC (GB) | 2013-11-07 | — | — | WO | disclosed |
| CN-103329907-A | Preparation method for fenethazine mycin biochemical germicide | SHANGHAI NONGLE BIOLOG PRODUCT CO LTD | 2013-10-02 | — | — | CN | disclosed |
| CN-103329907-A | Preparation method for fenethazine mycin biochemical germicide | SHANGHAI NONGLE BIOLOG PRODUCT CO LTD | 2013-10-02 | — | — | CN | disclosed |
| US-20130216483-A1 | DELIVERY SYSTEM FOR REMOTE TREATMENT OF AN ANIMAL | SMARTVET PTY LTD. (AU) | 2013-08-22 | — | — | US | disclosed |
| US-20130204238-A1 | COMBINATION THERAPY | FOLLICA, INC (US) | 2013-08-08 | — | — | US | disclosed |
| US-8454582-B2 | Methods and devices for the treatment of ocular conditions | SURMODICS, INC. (US) | 2013-06-04 | — | — | US | disclosed |
| US-8440170-B2 | Orally disintegrating tablets with speckled appearance | ALPEX PHARMA SA (CH) | 2013-05-14 | — | — | US | disclosed |
| EP-2589618-A1 | COMPOSITE PARTICLES WHICH CONTAIN BOTH CELLULOSE AND INORGANIC COMPOUND | Asahi Kasei Chemicals Corporation (JP) | 2013-05-08 | — | — | EP | disclosed |
| US-20130108872-A1 | COMPOSITE PARTICLES WHICH CONTAIN BOTH CELLULOSE AND INORGANIC COMPOUND | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2013-05-02 | — | — | US | disclosed |
| US-8425932-B2 | Delivery system for remote treatment of an animal | SMARTVET PTY LTD. (AU) | 2013-04-23 | — | — | US | disclosed |
| US-8414914-B2 | Compositions for mucosal delivery of agents | VIRUN, INC. (US) | 2013-04-09 | — | — | US | disclosed |
| CN-101557871-B | Granules, tablets and granulation | ATACAMA LABS OY | 2013-02-13 | — | — | CN | disclosed |
| EP-2552323-A1 | COMBINATION THERAPY | Follica, Inc. (US) | 2013-02-06 | — | — | EP | disclosed |
| US-20120322792-A1 | Method and Compositions for Treating Cancer and Related Methods | MOUNT SINAI SCHOOL OF MEDICINE (US) | 2012-12-20 | — | — | US | disclosed |
| WO-2012170676-A1 | CONTROLLED ABSORPTION WATER-SOLUBLE PHARMACEUTICALLY ACTIVE ORGANIC COMPOUND FORMULATION FOR ONCE-DAILY ADMINISTRATION | STI PHARMA, LLC (US) | 2012-12-13 | — | — | WO | disclosed |
| US-20120308644-A1 | Compositions for mucosal delivery of agents | ARCHIMEDES LABORATORIES, INC. | 2012-12-06 | — | — | US | disclosed |
| US-20120269881-A9 | TRANSDERMAL DRUG DELIVERY DEVICE INCLUDING AN OCCLUSIVE BACKING | NOVEN PHARMACEUTICALS, INC. | 2012-10-25 | — | — | US | disclosed |
| CN-102740854-A | Loxoprofen-containing pharmaceutical composition | KOWA CO | 2012-10-17 | — | — | CN | disclosed |
| CN-101355876-B | Composition suitable for ophthalmic administration | COMBINATORX INC | 2012-09-05 | — | — | CN | disclosed |
| US-8252749-B2 | Methods, kits, and compositions for generating new hair follicles and growing hair | FOLLICA, INC. (US) | 2012-08-28 | — | — | US | disclosed |
| US-8252323-B2 | Compositions for mucosal delivery of agents | VIRUN, INC. (US) | 2012-08-28 | — | — | US | disclosed |
| EP-1768647-B1 | COMPOSITIONS COMPRISING A MUCOADHESIVE PROTEIN AND AN ACTIVE PRINCIPLE FOR MUCOSAL DELIVERY OF SAID AGENT | VIRUN INC (US) | 2012-08-08 | — | — | EP | disclosed |
| WO-2012097054-A1 | METHODS AND COMPOSITIONS FOR TREATING CANCER AND RELATED METHODS | MOUNT SINAI SCHOOL OF MEDICINE (US) | 2012-07-19 | — | — | WO | disclosed |
| WO-2012096654-A1 | METHODS AND COMPOSITIONS FOR TREATING CANCER AND RELATED METHODS | MOUNT SINAI SCHOOL OF MEDICINE (US) | 2012-07-19 | — | — | WO | disclosed |
| US-20120165762-A1 | TRANSDERMAL DRUG DELIVERY DEVICE INCLUDING AN OCCLUSIVE BACKING | NOVEN PHARMACEUTICALS, INC. | 2012-06-28 | — | — | US | disclosed |
| US-20120156228-A1 | Methods, Kits, and Compositions for Generating New Hair Follicles and Growing Hair | FOLLICA, INC. (US) | 2012-06-21 | — | — | US | disclosed |
| US-20120141590-A1 | Technology for the Preparation of Microparticles | MALAKHOV MICHAEL (US) | 2012-06-07 | — | — | US | disclosed |
| WO-2012067630-A1 | HAIR GROWTH TREATMENT | FOLLICA, INC. (US) | 2012-05-24 | — | — | WO | disclosed |
| WO-2012067632-A1 | SEQUENTIAL BODY SURFACE TREATMENT | FOLLICA, INC. (US) | 2012-05-24 | — | — | WO | disclosed |
| WO-2012067631-A1 | BODY SURFACE TREATMENT | FOLLICA, INC. (US) | 2012-05-24 | — | — | WO | disclosed |
| US-20120116062-A1 | TECHNOLOGY FOR PREPARATION OF MACROMOLECULAR MICROSPHERES | ANSUN BIOPHARMA, INC. | 2012-05-10 | — | — | US | disclosed |
| US-8158152-B2 | Preparing lyophilizates, especially those free of undesired extra components such as mono- or disaccharides; dosage forms of a wide variety of over 2000 drugs, such as rapidly dissolving tablets | SCIDOSE LLC (US) | 2012-04-17 | — | — | US | disclosed |
| US-20120058979-A1 | METHODS AND REAGENTS FOR THE TREATMENT OF IMMUNOINFLAMMATORY DISORDERS | ZALICUS INC. (US) | 2012-03-08 | — | — | US | disclosed |
| US-20120046279-A1 | Oligomer-Phenothiazine Conjugates | NEKTAR THERAPEUTICS (US) | 2012-02-23 | — | — | US | disclosed |
| CN-101005828-B | Compositions comprising a mucoadhesive protein and an active principle for mucosal delivery of said agents | VIRUN INC | 2012-01-11 | — | — | CN | disclosed |
| US-8080553-B2 | Methods and reagents for the treatment of immunoinflammatory disorders | ZALICUS INC. (US) | 2011-12-20 | — | — | US | disclosed |
| US-8052999-B2 | Granules, tablets and granulation | ATACAMA LABS (FI) | 2011-11-08 | — | — | US | disclosed |
| WO-2011123218-A1 | COMBINATION THERAPY | FOLLICA, INC. (US) | 2011-10-06 | — | — | WO | disclosed |
| US-20110212173-A1 | Controlled Release Treatment of Depression | e-Therapeutics Ple (GB) | 2011-09-01 | — | — | US | disclosed |
| US-20110212173-A1 | Controlled Release Treatment of Depression | e-Therapeutics Ple (GB) | 2011-09-01 | — | — | US | disclosed |
| US-20110159073-A1 | METHODS AND DEVICES FOR THE TREATMENT OF OCULAR CONDITIONS | DEJUAN EUGENE | 2011-06-30 | — | — | US | disclosed |
| US-20110140298-A1 | METHOD AND APPARATUS OR DRY GRANULATION | ATACAMA LABS OY (FI) | 2011-06-16 | — | — | US | disclosed |
| US-20110130711-A1 | HAIR GROWTH TREATMENT | FOLLICA, INC. (US) | 2011-06-02 | — | — | US | disclosed |
| US-20110130748-A1 | BODY SURFACE TREATMENT | FOLLICA, INC. (US) | 2011-06-02 | — | — | US | disclosed |
| US-20110130706-A1 | SEQUENTIAL BODY SURFACE TREATMENT | FOLLICA, INC. (US) | 2011-06-02 | — | — | US | disclosed |
| US-20110117184-A1 | Compositions for mucosal delivery of agents | VIRUN, INC. | 2011-05-19 | — | — | US | disclosed |
| EP-2315585-A1 | CONTROLLED RELEASE TREATMENT OF DEPRESSION | E-Therapeutics plc (GB) | 2011-05-04 | — | — | EP | disclosed |
| EP-2315585-A1 | CONTROLLED RELEASE TREATMENT OF DEPRESSION | E-Therapeutics plc (GB) | 2011-05-04 | — | — | EP | disclosed |
| US-20110097384-A1 | TRANSDERMAL DRUG DELIVERY DEVICE INCLUDING AN OCCLUSIVE BACKING | NOVEN PHARMACEUTICALS, INC. | 2011-04-28 | — | — | US | disclosed |
| US-20110089087-A1 | GRANULES, TABLETS AND GRANULATION | POLITI GIOVANNI | 2011-04-21 | — | — | US | disclosed |
| WO-2010004256-A8 | CONTROLLED RELEASE TREATMENT OF DEPRESSION | E-THERAPEUTICS PLC (GB) | 2011-03-31 | — | — | WO | disclosed |
| EP-2301628-A1 | Methods and reagents for the treatment of immunoinflammatory disorders | Zalicus Inc. (US) | 2011-03-30 | — | — | EP | disclosed |
| US-20110062630-A1 | CELLULOSE POWDER HAVING EXCELLENT SEGREGATION PREVENTIVE EFFECT, AND COMPOSITIONS THEREOF | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2011-03-17 | — | — | US | disclosed |
| US-7905852-B2 | Skin-contacting-adhesive free dressing | JENNINGS-SPRING BARBARA | 2011-03-15 | — | — | US | disclosed |
| US-7906140-B2 | Compositions for mucosal delivery of agents | VIRUN, INC. (US) | 2011-03-15 | — | — | US | disclosed |
| EP-2291233-A1 | METHOD AND APPARATUS FOR DRY GRANULATION | Atacama Labs Oy (FI) | 2011-03-09 | — | — | EP | disclosed |
| EP-2287234-A1 | CELLULOSE POWDER HAVING EXCELLENT SEGREGATION PREVENTIVE EFFECT, AND COMPOSITIONS THEREOF | Asahi Kasei Chemicals Corporation (JP) | 2011-02-23 | — | — | EP | disclosed |
| EP-2285354-A2 | PROCESS FOR PREPARING A LOW DRUG LOAD TABLET | Atacama Labs Oy (FI) | 2011-02-23 | — | — | EP | disclosed |
| EP-2285355-A2 | PROCESS FOR PREPARING A HIGH DRUG LOAD TABLET | Atacama Labs Oy (FI) | 2011-02-23 | — | — | EP | disclosed |
| EP-2254558-A1 | ORALLY DISINTEGRATING TABLETS WITH SPECKLED APPEARANCE | Alpex Pharma SA (CH) | 2010-12-01 | — | — | EP | disclosed |
| US-20100298760-A1 | METHODS, KITS, AND COMPOSITIONS FOR ADMINISTERING PHARMACEUTICAL COMPOUNDS | PURETECH VENTURES | 2010-11-25 | — | — | US | disclosed |
| US-20100278754-A1 | ORALLY DISINTEGRATING TABLETS WITH SPECKLED APPEARANCE | ALPEX PHARMA SA (CH) | 2010-11-04 | — | — | US | disclosed |
| US-20100278784-A1 | METHODS AND COMPOSITIONS FOR TREATING SKIN CONDITIONS | PURETECH VENTURES (US) | 2010-11-04 | — | — | US | disclosed |
| CN-101848704-A | Techniques for preparing microparticles | NEXBIO INC | 2010-09-29 | — | — | CN | disclosed |
| US-20100226943-A1 | SURFACE TOPOGRAPHIES FOR NON-TOXIC BIOADHESION CONTROL | UNIVERSITY OF FLORIDA (US) | 2010-09-09 | — | — | US | disclosed |
| EP-2218442-A1 | Methods, compositions, and kits for the treatment of ophthalmic disorders | CombinatoRx, Inc. (US) | 2010-08-18 | — | — | EP | disclosed |
| US-20100203122-A1 | Delivery System for Remote Treatment of an Animal | SMARTVET PTY LTD. (AU) | 2010-08-12 | — | — | US | disclosed |
| EP-2214770-A1 | METHODS, KITS, AND COMPOSITIONS FOR ADMINISTERING PHARMACEUTICAL COMPOUNDS | Puretech Ventures (US) | 2010-08-11 | — | — | EP | disclosed |
| CN-101801361-A | Treatment of depression | THERAPEUTICS LTD E | 2010-08-11 | — | — | CN | disclosed |
| CN-101801361-A | Treatment of depression | THERAPEUTICS LTD E | 2010-08-11 | — | — | CN | disclosed |
| WO-2010088340-A1 | OLIGOMER-PHENOTHIAZINE CONJUGATES | NEKTAR THERAPEUTICS (US) | 2010-08-05 | — | — | WO | disclosed |
| US-20100184861-A1 | METHOD AND APPARATUS FOR DRY GRANULATION | ATACAMA LABS OY (FI) | 2010-07-22 | — | — | US | disclosed |
| US-20100166874-A1 | Technology for Preparation of Macromolecular Microspheres | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2010-07-01 | — | — | US | disclosed |
| US-20100120768-A1 | METHODS, KITS, AND COMPOSITIONS FOR GENERATING NEW HAIR FOLLICLES AND GROWING HAIR | LIGHTHOUSE CAPITAL PARTNERS VI, L.P. | 2010-05-13 | — | — | US | disclosed |
| EP-2173327-A2 | TECHNOLOGY FOR THE PREPARATION OF MICROPARTICLES | Nexbio, Inc. (US) | 2010-04-14 | — | — | EP | disclosed |
| US-20100081713-A1 | COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS | CombinatoRx, (Singapore) Pte. Ltd. | 2010-04-01 | — | — | US | disclosed |
| US-20100069323-A1 | COMPOSITION FOR APPLICATION TO SKIN OR MUCOSA | ROHTO PHARMACEUTICAL CO., LTD. (JP) | 2010-03-18 | — | — | US | disclosed |
| WO-2010024870-A1 | SKIN-CONTACTING-ADHESIVE FREE DRESSING | JENNINGS-SPRING BARBARA BROOKE (US) | 2010-03-04 | — | — | WO | disclosed |
| EP-2155146-A1 | METHODS AND COMPOSITIONS FOR TREATING SKIN CONDITIONS | Puretech Ventures (US) | 2010-02-24 | — | — | EP | disclosed |
| WO-2010004256-A1 | CONTROLLED RELEASE TREATMENT OF DEPRESSION | E-THERAPEUTICS PLC (GB) | 2010-01-14 | — | — | WO | disclosed |
| WO-2010004256-A1 | CONTROLLED RELEASE TREATMENT OF DEPRESSION | E-THERAPEUTICS PLC (GB) | 2010-01-14 | — | — | WO | disclosed |
| US-20100009970-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF VIRAL DISEASES | COMBINATORX (SINGAPORE) PTE. LTD. (SG) | 2010-01-14 | — | — | US | disclosed |
| WO-2009135946-A1 | METHOD AND APPARATUS FOR DRY GRANULATION | ATACAMA LABS OY (FI) | 2009-11-12 | — | — | WO | disclosed |
| WO-2009135950-A2 | PROCESS FOR PREPARING A TABLET CONTAINING EXCIPIENTS | ATACAMA LABS OY (FI) | 2009-11-12 | — | — | WO | disclosed |
| WO-2009135949-A2 | PROCESS FOR PREPARING A VERY HIGH DRUG LOAD TABLET | ATACAMA LABS OY (FI) | 2009-11-12 | — | — | WO | disclosed |
| WO-2009135947-A2 | PROCESS FOR PREPARING A LOW DRUG LOAD TABLET | ATACAMA LABS OY (FI) | 2009-11-12 | — | — | WO | disclosed |
| WO-2009135948-A2 | PROCESS FOR PREPARING A HIGH DRUG LOAD TABLET | ATACAMA LABS OY (FI) | 2009-11-12 | — | — | WO | disclosed |
| CN-101557871-A | Granules, tablets and granulation | ATACAMA LABS OY (FI) | 2009-10-14 | — | — | CN | disclosed |
| CN-101534863-A | Composition for application to the skin or mucosa | ROHTO PHARMA (JP) | 2009-09-16 | — | — | CN | disclosed |
| WO-2009098169-A1 | ORALLY DISINTEGRATING TABLETS WITH SPECKLED APPEARANCE | ALPEX PHARMA SA (CH) | 2009-08-13 | — | — | WO | disclosed |
| EP-2081669-A2 | GRANULES, TABLETS AND GRANULATION | Atacama Labs OY (FI) | 2009-07-29 | — | — | EP | disclosed |
| EP-1846448-B1 | DIAGNOSIS OF ALLERGIC COMPLAINTS, ATOPIC DISEASES AND/OR AUTO-IMMUNE DISEASES BY THE IDENTIFICATION OF ANTIBODIES AGAINST CD28 IN HUMAN SERUM | UNIVERSITAETSKLINIKUM HAMBURG (DE) | 2009-07-22 | — | — | EP | disclosed |
| EP-2077819-A2 | METHODS, KITS, AND COMPOSITIONS FOR GENERATING NEW HAIR FOLLICLES AND GROWING HAIR | Follica, Inc. (US) | 2009-07-15 | — | — | EP | disclosed |
| EP-2070550-A1 | Use of combinations comprising a corticosteroid and a pyrimidopyrimidine in the treatment of inflammatory diseases | Combinatorx, Incorporated (US) | 2009-06-17 | — | — | EP | disclosed |
| WO-2009061349-A1 | METHODS, KITS, AND COMPOSITIONS FOR ADMINISTERING PHARMACEUTICAL COMPOUNDS | PURETECH VENTURES (US) | 2009-05-14 | — | — | WO | disclosed |
| US-20090098207-A1 | Technology for the Preparation of Microparticles | NEXBIO, INC. (US) | 2009-04-16 | — | — | US | disclosed |
| CN-101404980-A | Preparation Technology of Macromolecular Microspheres | NEXBIO INC (US) | 2009-04-08 | — | — | CN | disclosed |
| WO-2009001040-A3 | TREATMENT OF DEPRESSION | E THERAPEUTICS PLC (GB) | 2009-02-19 | — | — | WO | disclosed |
| EP-2014282-A3 | Treatment of depression | E-Therapeutics plc (GB) | 2009-02-18 | — | — | EP | disclosed |
| WO-2009015286-A2 | TECHNOLOGY FOR THE PREPARATION OF MICROPARTICLES | NEXBIO, INC. (US) | 2009-01-29 | — | — | WO | disclosed |
| CN-101355876-A | Methods, compositions and kits for treating medical conditions | COMBINATORX INC (US) | 2009-01-28 | — | — | CN | disclosed |
| EP-2014282-A2 | Treatment of depression | E-Therapeutics plc (GB) | 2009-01-14 | — | — | EP | disclosed |
| EP-2014282-A2 | Treatment of depression | E-Therapeutics plc (GB) | 2009-01-14 | — | — | EP | disclosed |
| EP-1670427-A4 | METHODS AND REAGENTS FOR THE TREATMENT OF IMMUNOINFLAMMATORY DISORDERS | COMBINATORX INC (US) | 2009-01-07 | — | — | EP | disclosed |
| US-20090005443-A1 | Treatment of Depression | E-THERAPEUTICS LIMITED (GB) | 2009-01-01 | — | — | US | disclosed |
| US-20090005722-A1 | Skin-contacting-adhesive free dressing | JENNLNGS-SPRING BARBARA | 2009-01-01 | — | — | US | disclosed |
| US-20090005443-A1 | Treatment of Depression | E-THERAPEUTICS LIMITED (GB) | 2009-01-01 | — | — | US | disclosed |
| WO-2009001040-A2 | TREATMENT OF DEPRESSION | E-THERAPEUTICS PLC (GB) | 2008-12-31 | — | — | WO | disclosed |
| WO-2009001040-A2 | TREATMENT OF DEPRESSION | E-THERAPEUTICS PLC (GB) | 2008-12-31 | — | — | WO | disclosed |
| WO-2008143928-A1 | METHODS AND COMPOSITIONS FOR TREATING SKIN CONDITIONS | PURETECH VENTURES (US) | 2008-11-27 | — | — | WO | disclosed |
| WO-2008133884-A2 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS | COMBINATORX, INCORPORATED (US) | 2008-11-06 | — | — | WO | disclosed |
| EP-1981483-A1 | TECHNOLOGY FOR PREPARATION OF MACROMOLECULAR MICROSPHERES | Nexbio, Inc. (US) | 2008-10-22 | — | — | EP | disclosed |
| EP-1956906-A2 | METHODS, COMPOSITIONS, AND KITS FOR THE TREATMENT OF MEDICAL CONDITIONS | CombinatoRx, Incorporated (US) | 2008-08-20 | — | — | EP | disclosed |
| EP-0705111-B1 | AGENT WITH INFLUENCES HYPERACTIVE IMMUNOLOGICAL EFFECTOR CELLS | LESKOVAR PETER (DE) | 2008-08-20 | — | — | EP | disclosed |
| EP-1954244-A1 | LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY | Scidose, Llc (US) | 2008-08-13 | — | — | EP | disclosed |
| US-20080161324-A1 | Compositions and methods for treatment of viral diseases | EXCRX (SINGAPORE) PTE. LTD. (F.K.A. COMBINATORX (SINGAPORE) PTE LTD.) (SG) | 2008-07-03 | — | — | US | disclosed |
| US-20080124396-A1 | Inhibition of Xenoreactive Antibodies | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) | 2008-05-29 | — | — | US | disclosed |
| US-20080124396-A1 | Inhibition of Xenoreactive Antibodies | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) | 2008-05-29 | — | — | US | disclosed |
| WO-2008056021-A2 | GRANULES, TABLETS AND GRANULATION | ATACAMA LABS OY (FI) | 2008-05-15 | — | — | WO | disclosed |
| US-20080111269-A1 | Granules, tablets and granulation | ATACAMA LABS (FI) | 2008-05-15 | — | — | US | disclosed |
| WO-2008052263-A1 | DELIVERY SYSTEM FOR REMOTE TREATMENT OF AN ANIMAL | VETERINARY ENCAPSULATION BIOSCIENCES PTY LTD (AU) | 2008-05-08 | — | — | WO | disclosed |
| WO-2008042216-A2 | METHODS, KITS, AND COMPOSITIONS FOR GENERATING NEW HAIR FOLLICLES AND GROWING HAIR | FOLLICA, INC. (US) | 2008-04-10 | — | — | WO | disclosed |
| EP-1904031-A2 | A SUBSTANTIALLY WATER-FREE PRESSURISED PROPELLANT MIXTURE | THERAPICON SRL (IT) | 2008-04-02 | — | — | EP | disclosed |
| WO-2008033466-A2 | COMPOSITIONS AND METHODS FOR TREATMENT OF VIRAL DISEASES | COMBINATORX (SINGAPORE) PRE. LTD. (SG) | 2008-03-20 | — | — | WO | disclosed |
| US-20080063698-A1 | Crystallization inhibition of drugs in transdermal drug delivery systems and methods of use | NOVEN PHARMACEUTICALS, INC. | 2008-03-13 | — | — | US | disclosed |
| CN-101102760-A | Methods and agents for treating immunoinflammatory disorders | COMBINATORX (US) | 2008-01-09 | — | — | CN | disclosed |
| US-20070299043-A1 | Anti-scarring drug combinations and use thereof | HUNTER WILLIAM L | 2007-12-27 | — | — | US | disclosed |
| EP-1680121-A4 | METHODS AND REAGENTS FOR THE TREATMENT OF IMMUNOINFLAMMATORY DISORDERS | COMBINATORX INC (US) | 2007-12-26 | — | — | EP | disclosed |
| EP-1846448-A1 | DIAGNOSIS OF ALLERGIC COMPLAINTS, ATOPIC DISEASES AND/OR AUTO-IMMUNE DISEASES BY THE IDENTIFICATION OF ANTIBODIES AGAINST CD28 IN HUMAN SERUM | Universitätsklinikum Hamburg-Eppendorf (DE) | 2007-10-24 | — | — | EP | disclosed |
| WO-2007114881-A1 | TECHNOLOGY FOR PREPARATION OF MACROMOLECULAR MICROSPHERES | NEXBIO, INC. (US) | 2007-10-11 | — | — | WO | disclosed |
| EP-1675550-A4 | THERAPEUTIC REGIMENS FOR ADMINISTERING DRUG COMBINATIONS | COMBINATORX INC (US) | 2007-10-10 | — | — | EP | disclosed |
| US-20070225217-A1 | Methods, compositions, and kits for the treatment of medical conditions | COMBINATORX, INCORPORATED (US) | 2007-09-27 | — | — | US | disclosed |
| US-20070208134-A1 | Anti-scarring drug combinations and use thereof | HUNTER WILLIAM L | 2007-09-06 | — | — | US | disclosed |
| US-20070196421-A1 | Soft tissue implants and drug combination compositions, and use thereof | ANGIOTECH INTERNATIONAL AG (CH) | 2007-08-23 | — | — | US | disclosed |
| US-20070198063-A1 | Electrical devices and anti-scarring drug combinations | HUNTER WILLIAM L | 2007-08-23 | — | — | US | disclosed |
| US-20070197957-A1 | Implantable sensors, implantable pumps and anti-scarring drug combinations | HUNTER WILLIAM L | 2007-08-23 | — | — | US | disclosed |
| US-20070190163-A1 | Technology for preparation of macromolecular microspheres | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, NATIONAL INSTITUTE OF HEALTH | 2007-08-16 | — | — | US | disclosed |
| US-20070190017-A1 | Porous cellulose aggregate and formed product composition comprising the same | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2007-08-16 | — | — | US | disclosed |
| CN-101005828-A | Compositions comprising a mucoadhesive protein and an activeprinciple for mucosal delivery of said agents | VIRUN INC (US) | 2007-07-25 | — | — | CN | disclosed |
| EP-1807033-A2 | TRANSDERMAL DRUG DELIVERY DEVICE INCLUDING AN OCCLUSIVE BACKING | NOVEN PHARMACEUTICALS, INC. (US) | 2007-07-18 | — | — | EP | disclosed |
| CN-1993051-A | Treatment regimens for combination administration | COMBINATORX INC (US) | 2007-07-04 | — | — | CN | disclosed |
| EP-1796661-A2 | LARGE-SCALE MANUFACTURING PROCESS FOR THE PRODUCTION OF PHARMACEUTICAL COMPOSITIONS | Naryx Pharma, Inc. (US) | 2007-06-20 | — | — | EP | disclosed |
| WO-2007061529-A1 | LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY | SCIDOSE LLC. (US) | 2007-05-31 | — | — | WO | disclosed |
| WO-2007041677-A9 | SOFT TISSUE IMPLANTS AND DRUG COMBINATION COMPOSITIONS, AND USE THEREOF | COMBINATORX INC (US) | 2007-05-31 | — | — | WO | disclosed |
| US-20070116729-A1 | Lyophilization process and products obtained thereby | SCIDOSE LLC | 2007-05-24 | — | — | US | disclosed |
| EP-0665289-B1 | Peptides from GAD65, provoking autoimmune reactions | ROCHE DIAGNOSTICS GMBH (DE) | 2007-05-23 | — | — | EP | disclosed |
| WO-2007056457-A2 | METHODS, COMPOSITIONS, AND KITS FOR THE TREATMENT OF MEDICAL CONDITIONS | COMBINATORX, INCORPORATED (US) | 2007-05-18 | — | — | WO | disclosed |
| WO-2007041593-A2 | ANTI-SCARRING DRUG COMBINATIONS AND USE THEREOF | COMBINATORX, INCORPORATED (US) | 2007-04-12 | — | — | WO | disclosed |
| WO-2007041584-A2 | IMPLANTABLE SENSORS, IMPLANTABLE PUMPS, AND ANTI-SCARRING DRUG COMBINATIONS | COMBINATORX, INCORPORATED (US) | 2007-04-12 | — | — | WO | disclosed |
| WO-2007041463-A2 | ELECTRICAL DEVICES AND ANTI-SCARRING DRUG COMBINATIONS | COMBINATORX, INCORPORATED (US) | 2007-04-12 | — | — | WO | disclosed |
| WO-2007041677-A2 | SOFT TISSUE IMPLANTS AND DRUG COMBINATION COMPOSITIONS, AND USE THEREOF | COMBINATORX, INCORPORATED (US) | 2007-04-12 | — | — | WO | disclosed |
| EP-1768647-A1 | COMPOSITIONS COMPRISING A MUCOADHESIVE PROTEIN AND AN ACTIVE PRINCIPLE FOR MUCOSAL DELIVERY OF SAID AGENT | Virun, Inc. (US) | 2007-04-04 | — | — | EP | disclosed |
| CN-1902488-A | Screening assays and methods of tumor treatment | GENENTECH INC (US) | 2007-01-24 | — | — | CN | disclosed |
| US-20070010502-A1 | Methods and reagents for the treatment of immunoinflammatory disorders | COMBINATORX INC. (US) | 2007-01-11 | — | — | US | disclosed |
| CN-1889956-A | Methods and reagents for the treatment of immunoinflammatory disorders | COMBINATORX INC (US) | 2007-01-03 | — | — | CN | disclosed |
| WO-2006122905-A2 | A SUBSTANTIALLY WATER-FREE PRESSURISED PROPELLANT MIXTURE | THERAPICON SRL (IT) | 2006-11-23 | — | — | WO | disclosed |
| EP-1712583-A1 | POROUS CELLULOSE AGGREGATE AND FORMED PRODUCT COMPOSITION COMPRISING THE SAME | Asahi Kasei Chemicals Corporation (JP) | 2006-10-18 | — | — | EP | disclosed |
| US-7122198-B1 | Fast dissolving composition with prolonged sweet taste | PANACEA BIOTEC LIMITED (IN) | 2006-10-17 | — | — | US | disclosed |
| WO-2006082066-A1 | DIAGNOSIS OF ALLERGIC COMPLAINTS, ATOPIC DISEASES AND/OR AUTO-IMMUNE DISEASES BY THE IDENTIFICATION OF ANTIBODIES AGAINST CD28 IN HUMAN SERUM | Universitätsklinikum Hamburg-Eppendorf (DE) | 2006-08-10 | — | — | WO | disclosed |
| EP-1680121-A2 | METHODS AND REAGENTS FOR THE TREATMENT OF IMMUNOINFLAMMATORY DISORDERS | CombinatoRx, Incorporated (US) | 2006-07-19 | — | — | EP | disclosed |
| EP-1675550-A2 | THERAPEUTIC REGIMENS FOR ADMINISTERING DRUG COMBINATIONS | CombinatoRx, Incorporated (US) | 2006-07-05 | — | — | EP | disclosed |
| EP-1670427-A2 | METHODS AND REAGENTS FOR THE TREATMENT OF IMMUNOINFLAMMATORY DISORDERS | CombinatoRx, Incorporated (US) | 2006-06-21 | — | — | EP | disclosed |
| US-20060110428-A1 | Methods and devices for the treatment of ocular conditions | SURMODICS MD, LLC | 2006-05-25 | — | — | US | disclosed |
| US-20060099256-A1 | Microspheres and related processes and pharmaceutical compositions | PRICE JAMES C | 2006-05-11 | — | — | US | disclosed |
| WO-2006044206-A2 | TRANSDERMAL DRUG DELIVERY DEVICE INCLUDING AN OCCLUSIVE BACKING | NOVEN PHARMACEUTICALS, INC. (US) | 2006-04-27 | — | — | WO | disclosed |
| WO-2006041592-A2 | LARGE-SCALE MANUFACTURING PROCESS FOR THE PRODUCTION OF PHARMACEUTICAL COMPOSITIONS | NARYX PHARMA, INC. (US) | 2006-04-20 | — | — | WO | disclosed |
| CN-1761478-A | Combination therapy for the treatment of immunoinflammatory disorders | COMBINATORX INC (US) | 2006-04-19 | — | — | CN | disclosed |
| US-20060078604-A1 | Transdermal drug delivery device including an occlusive backing | NOVEN PHARMACEUTICALS, INC. | 2006-04-13 | — | — | US | disclosed |
| EP-1644487-A1 | REGULATORY T-CELLS CONTAINING GALECTINS FOR THE THERAPY AND DIAGNOSIS OF DISEASES | Protagen AG (DE) | 2006-04-12 | — | — | EP | disclosed |
| US-20060073173-A1 | Large-scale manufacturing process for the production of pharmaceutical compositions | NARYX PHARMA, INC. | 2006-04-06 | — | — | US | disclosed |
| US-7001892-B1 | Pharmaceutical materials and methods for their preparation and use | PURDUE RESEARCH FOUNDATION (US) | 2006-02-21 | — | — | US | disclosed |
| WO-2006014484-A2 | METHODS AND DEVICES FOR THE TREATMENT OF OCULAR CONDITIONS | SURMODICS, INC. (US) | 2006-02-09 | — | — | WO | disclosed |
| EP-1599212-A4 | COMBINATION THERAPY FOR THE TREATMENT OF IMMUNOINFLAMMATORY DISORDERS | COMBINATORX INC (US) | 2006-02-08 | — | — | EP | disclosed |
| WO-2006009825-A1 | COMPOSITIONS COMPRISING A MUCOADHESIVE PROTEIN AND AN ACTIVE PRINCIPLE FOR MUCOSAL DELIVERY OF SAID AGENTS | VIRUN, INC. (US) | 2006-01-26 | — | — | WO | disclosed |
| WO-2006001815-A1 | ACTIVE AGENTS USING LIPOSOME MACRO-BEADS | SUVANPRAKORN PICHIT (TH) | 2006-01-05 | — | — | WO | disclosed |
| EP-1021204-B1 | BIOADHESIVE COMPOSITIONS AND METHODS FOR TOPICAL ADMINISTRATION OF ACTIVE AGENTS | NOVEN PHARMA (US) | 2005-12-28 | — | — | EP | disclosed |
| US-20050281772-A1 | Compositions for mucosal delivery of agents | VIRUN, INC. | 2005-12-22 | — | — | US | disclosed |
| EP-1599212-A2 | COMBINATION THERAPY FOR THE TREATMENT OF IMMUNOINFLAMMATORY DISORDERS | Combinatorx, Incorporated (US) | 2005-11-30 | — | — | EP | disclosed |
| WO-2005094832-A1 | COMPOSITIONS COMPRISING MELOXICAM | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2005-10-13 | — | — | WO | disclosed |
| EP-1087791-B1 | INHIBITION OF XENOREACTIVE ANTIBODIES | MAYO FOUNDATION (US) | 2005-09-21 | — | — | EP | disclosed |
| EP-1087791-B1 | INHIBITION OF XENOREACTIVE ANTIBODIES | MAYO FOUNDATION (US) | 2005-09-21 | — | — | EP | disclosed |
| US-20050192261-A1 | Methods and reagents for the treatment of immunoinflammatory disorders | COMBINATORX INCORPORATED | 2005-09-01 | — | — | US | disclosed |
| US-20050166269-A1 | Sleep genes in Drosophila and their use for the screening, diagnosis and therapy of sleep disorders | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2005-07-28 | — | — | US | disclosed |
| WO-2005061736-A2 | SLEEP GENES IN DROSOPHILA AND THEIR USE FOR THE SCREENING, DIAGNOSIS AND THERAPY OF SLEEP DISORDERS | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2005-07-07 | — | — | WO | disclosed |
| US-20050119160-A1 | Methods and reagents for the treatment of immunoinflammatory disorders | ZALICUS INC. | 2005-06-02 | — | — | US | disclosed |
| US-20050112199-A1 | Therapeutic regimens for administering drug combinations | COMBINATORX, INCORPORATED | 2005-05-26 | — | — | US | disclosed |
| CN-1202261-C | Methods for making recombinant cells | SUNOL MOLECULAR CORP (US) | 2005-05-18 | — | — | CN | disclosed |
| WO-2005037203-A2 | METHODS AND REAGENTS FOR THE TREATMENT OF IMMUNOINFLAMMATORY DISORDERS | COMBINATORX, INCORPORATED (US) | 2005-04-28 | — | — | WO | disclosed |
| WO-2005030132-A2 | THERAPEUTIC REGIMENS FOR ADMINISTERING DRUG COMBINATIONS | COMBINATORX, INCORPORATED (US) | 2005-04-07 | — | — | WO | disclosed |
| WO-2005027839-A2 | METHODS AND REAGENTS FOR THE TREATMENT OF IMMUNOINFLAMMATORY DISORDERS | COMBINATORX, INCORPORATED (US) | 2005-03-31 | — | — | WO | disclosed |
| CN-1582142-A | Ibuprofen salt emulsifiers and cream formulations containing same | MACROCHEM CORP (US) | 2005-02-16 | — | — | CN | disclosed |
| US-20050032900-A1 | Ibuprofen salt emulsifiers and cream formulations containing same | MACROCHEM CORPORATION | 2005-02-10 | — | — | US | disclosed |
| WO-2005007836-A1 | REGULATORY T-CELLS CONTAINING GALECTINS FOR THE THERAPY AND DIAGNOSIS OF DISEASES | PROTAGEN AG (DE) | 2005-01-27 | — | — | WO | disclosed |
| US-20050002865-A1 | Diagnostic/therapeutic agents | AMERSHAM HEALTH AS (NO) | 2005-01-06 | — | — | US | disclosed |
| US-20040224012-A1 | Topical application and methods for administration of active agents using liposome macro-beads | BIOPHILE CORPORATION LTD. (TH) | 2004-11-11 | — | — | US | disclosed |
| US-20040224876-A1 | Combination therapy for the treatment of immunoinflammatory disorders | COMBINATORX, INCORPORATED | 2004-11-11 | — | — | US | disclosed |
| EP-1137808-B1 | METHODS FOR MAKING RECOMBINANT CELLS | SUNOL MOLECULAR CORP (US) | 2004-09-29 | — | — | EP | disclosed |
| WO-2004073614-A2 | COMBINATION THERAPY FOR THE TREATMENT OF IMMUNOINFLAMMATORY DISORDERS | COMBINATORX, INCORPORATED (US) | 2004-09-02 | — | — | WO | disclosed |
| US-20040156859-A1 | GP-41 peptides, BBB peptides, anticancer agents, antihistamines, bronchodilators, hypotensive agents, antiangina agents, opioids, analgesics, antidepressants, and hypothyroid agents reactive with amino, hydroxyl or thiol groups | CONJUCHEM, INC. (CA) | 2004-08-12 | — | — | US | disclosed |
| US-20040141922-A1 | Diagnostic/therapeutic agents | NYCOMED IMAGING AS | 2004-07-22 | — | — | US | disclosed |
| US-20040141944-A1 | Inhibition of xenoreactive antibodies | BIOSCIENCE 2002 LLC | 2004-07-22 | — | — | US | disclosed |
| US-20040141944-A1 | Inhibition of xenoreactive antibodies | BIOSCIENCE 2002 LLC | 2004-07-22 | — | — | US | disclosed |
| US-20040142023-A1 | Crystallization inhibition of drugs in transdermal drug delivery systems and methods of use | NOVEN PHARMACEUTICALS, INC. | 2004-07-22 | — | — | US | disclosed |
| EP-1432405-A1 | IBUPROFEN SALT EMULSIFIERS AND CREAM FORMULATIONS CONTAINING SAME | MacroChem Corporation (US) | 2004-06-30 | — | — | EP | disclosed |
| WO-2004050066-A1 | MICROSPHERES AND RELATED PROCESSES AND PHARMACEUTICAL COMPOSITIONS | THE UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2004-06-17 | — | — | WO | disclosed |
| US-20040115258-A1 | Oral pharmaceutical compositions containing cyclodextrins as taste masking agent | ELAN PHARMA SA (CH) | 2004-06-17 | — | — | US | disclosed |
| US-6706892-B1 | ADMINSTERING MALEIMIDE DERIVATIVE TO COVALENTLY BOND PROTEIN; WOUND HEALING, ANTIBIOTIC, ANTIINFLAMMATORY, ANTICARCINOGENIC, HYPOTENSIVE, AND ANALGESIC AGENTS | CONJUCHEM, INC. (CA) | 2004-03-16 | — | — | US | disclosed |
| US-20040018241-A1 | Bioadhesive compositions and methods for topical administration of active agents | NOVEN PHARMACEUTICALS, INC. | 2004-01-29 | — | — | US | disclosed |
| US-6680047-B2 | FOR USE IN ULTRASOUND IMAGING, CONTRAST AGENTS | AMERSHAM HEALTH AS (NO) | 2004-01-20 | — | — | US | disclosed |
| US-6638528-B1 | Pressure-sensitive adhesive matrix comprising blend of polyacrylate, polysiloxane, polyisobutylene, polyisoprene, polyamide or polystyrene; and insoluble, non-adhesive ethyl cellulose; polyvinylpyrrolidone crystallization inhibitor | NOVEN PHARMACEUTICALS, INC. | 2003-10-28 | — | — | US | disclosed |
| EP-1347781-A1 | ORAL PHARMACEUTICAL COMPOSITIONS CONTAINING CYCLODEXTRINS AS TASTE MASKING AGENT | ELAN CORPORATION, Plc (IE) | 2003-10-01 | — | — | EP | disclosed |
| EP-1336602-A1 | Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases | Scaramuzzino, Giovanni (IT) | 2003-08-20 | — | — | EP | disclosed |
| US-20030152616-A1 | Crystallization inhibition of drugs in transdermal drug delivery systems and methods of use | NOVEN PHARMACEUTICALS, INC. | 2003-08-14 | — | — | US | disclosed |
| US-6572867-B1 | Reducing plasma levels of anti-( alpha Gal(1,3)Gal) antibodies; nonimmunogenic polymers comprise alpha Gal(1,3) Gal moieties covalently linked to said polymer; cross-links are covalent tethers, derived from N-hydroxysulfosuccinimide | BAXTER INTERNATIONAL INC. | 2003-06-03 | — | — | US | disclosed |
| US-6572867-B1 | Reducing plasma levels of anti-( alpha Gal(1,3)Gal) antibodies; nonimmunogenic polymers comprise alpha Gal(1,3) Gal moieties covalently linked to said polymer; cross-links are covalent tethers, derived from N-hydroxysulfosuccinimide | BAXTER INTERNATIONAL INC. | 2003-06-03 | — | — | US | disclosed |
| EP-1310247-A1 | (+)-ephedrine as a sympathomimetic drug | Warner-Lambert Company LLC (US) | 2003-05-14 | — | — | EP | disclosed |
| EP-1030659-B1 | Pharmaceutical composition comprising (+)-EPHEDRINE and an H1 receptor antagonist | WARNER LAMBERT CO (US) | 2003-05-14 | — | — | EP | disclosed |
| US-6562363-B1 | Bioadhesive compositions and methods for topical administration of active agents | NOVEN PHARMACEUTICALS, INC. | 2003-05-13 | — | — | US | disclosed |
| WO-2003030818-A2 | ACTIVE AGENTS USING LIPOSOME BEADS | SUVANPRAKORN PICHIT (TH) | 2003-04-17 | — | — | WO | disclosed |
| US-20030068365-A1 | Compositions and methods for administration of active agents using liposome beads | BIOPHILE CORPORATION, LTD. (TH) | 2003-04-10 | — | — | US | disclosed |
| WO-2003028702-A1 | IBUPROFEN SALT EMULSIFIERS AND CREAM FORMULATIONS CONTAINING SAME | MACROCHEM CORPORATION (US) | 2003-04-10 | — | — | WO | disclosed |
| JP-2003012514-A | MEDICAMENT COMPOSITION | TAISHO PHARMACEUT CO LTD | 2003-01-15 | — | — | JP | disclosed |
| CN-1092925-C | Metribuzin-amide herbicide composition and preparation thereof | INST OF PLANT AND ENVIRONMENT (CN) | 2002-10-23 | — | — | CN | disclosed |
| US-6465004-B1 | ESTERIFIED OR ACYLATED CELLULOSE TO STABILIZE THE CONCENTRATION OF THE ACTIVE AGENT IN THE COMPOSITION AND TO INHIBIT CRYSTAL FORMATION; PRESSURE-SENSITIVE ADHESIVE CARRIER; CELLULOSE ACETATE BUTYRATE | NOVEN PHARMACEUTICALS, INC. | 2002-10-15 | — | — | US | disclosed |
| EP-1137808-A4 | METHODS FOR MAKING RECOMBINANT CELLS | SUNOL MOLECULAR CORP (US) | 2002-10-02 | — | — | EP | disclosed |
| EP-1235561-A2 | FAST DISSOLVING COMPOSITION WITH PROLONGED SWEET TASTE | Panacea Biotec Limited (IN) | 2002-09-04 | — | — | EP | disclosed |
| EP-1235618-A2 | BIOCONJUGATION IN VIVO TO PULMONARY OR BLOOD COMPONENTS | Conjuchem, Inc. (CA) | 2002-09-04 | — | — | EP | disclosed |
| US-20020106402-A1 | Crystallization inhibition of drugs in transdermal drug delivery systems and methods of use | NOVEN PHARMACEUTICALS, INC. | 2002-08-08 | — | — | US | disclosed |
| US-20020102215-A1 | Diagnostic/therapeutic agents | NYCOMED IMAGING AS | 2002-08-01 | — | — | US | disclosed |
| US-20020102217-A1 | Diagnostic/therapeutic agents | NYCOMED IMAGING AS | 2002-08-01 | — | — | US | disclosed |
| EP-1223216-A1 | Intracellular nucleic acid inhibitors of small guanine-nucleotide-exchange factors | NascaCell GmbH (DE) | 2002-07-17 | — | — | EP | disclosed |
| WO-2002053731-A1 | INTRACELLULAR NUCLEIC ACID INHIBITORS OF SMALL GUANINE NUCLEOTIDE EXCHANGE FACTORS | NASCACELL GMBH (DE) | 2002-07-11 | — | — | WO | disclosed |
| WO-2000076480-A9 | PHARMACEUTICAL MATERIALS AND METHODS FOR THEIR PREPARATION AND USE | LILLY CO ELI (US) | 2002-07-11 | — | — | WO | disclosed |
| WO-2002045701-A2 | CRYSTALLIZATION INHIBITION OF DRUGS IN TRANSDERMAL DRUG DELIVERY SYSTEMS | NOVEN PHARMACEUTICALS, INC. (US) | 2002-06-13 | — | — | WO | disclosed |
| WO-2002041920-A1 | ORAL PHARMACEUTICAL COMPOSITIONS CONTAINING CYCLODEXTRINS AS TASTE MASKING AGENT | ELAN CORPORATION, PLC (US) | 2002-05-30 | — | — | WO | disclosed |
| EP-1189599-A2 | PHARMACEUTICAL MATERIALS AND METHODS FOR THEIR PREPARATION AND USE | ELI LILLY AND COMPANY (US) | 2002-03-27 | — | — | EP | disclosed |
| US-20020004065-A1 | Compositions and methods to effect the release profile in the transdermal administration of active agents | KANIOS DAVID (US) | 2002-01-10 | — | — | US | disclosed |
| CN-1328605-A | Method for producing recombinant cell | SUNOL MOLECULAR CORP (US) | 2001-12-26 | — | — | CN | disclosed |
| US-6331289-B1 | ULTRASOUND CONTRAST AGENTS, SUSPENSION IN AQUEOUS CARRIER LIQUID OF A REPORTER COMPRISING GAS-CONTAINING OR GAS-GENERATING MATERIAL, AGENT CAPABLE OF FORMING AT LEAST TWO TYPES OF BINDING PAIRS WITH TARGET; REPORTER BEING CONJUGATED | NYCOMED IMAGING AS (NO) | 2001-12-18 | — | — | US | disclosed |
| WO-2001091799-A2 | MEDICAMENT FOR THE TREATMENT OF IMMUNE REACTIONS IN THE EYE | MOLOGEN FORSCHUNGS-, ENTWICKLUNGS- UND VERTRIEBS GMBH (DE) | 2001-12-06 | — | — | WO | disclosed |
| US-6306605-B1 | HIGH LEVEL EXPRESSION OF AN AMINO ACID SEQUENCE BY INTRODUCING VECTORS OF SELECTABLE SEQUENCES LINKED TO SEGMENT ENCODING AT LEAST ONE COPY OF AMINO ACID SEQUENCE, CULTURING TO SELECT VECTORS, ISOLATING CELLS EXPRESSING THE SEQUENCE | SUNOL MOLECULAR CORPORATION | 2001-10-23 | — | — | US | disclosed |
| EP-1137808-A1 | METHODS FOR MAKING RECOMBINANT CELLS | Sunol Molecular Corporation (US) | 2001-10-04 | — | — | EP | disclosed |
| WO-2001052823-A2 | COMPOSITIONS TO EFFECT THE RELEASE PROFILE IN THE TRANSDERMAL ADMINISTRATION OF DRUGS | NOVEN PHARMACEUTICALS, INC. (US) | 2001-07-26 | — | — | WO | disclosed |
| US-6264917-B1 | MIXTURE OF GAS FILLED MICROBUBBLES AND RELEASING AGENT | NYCOMED IMAGING AS (NO) | 2001-07-24 | — | — | US | disclosed |
| US-6261537-B1 | TARGETS AND ULTRASOUND DIAGNOSIS OF ACTIVE MATERIALS, AQUEOUS CARRIER LIQUIDS, CARRIERS AND FILM FORMING SURFACTANT PHOSPHATIDES | NYCOMED IMAGING AS (NO) | 2001-07-17 | — | — | US | disclosed |
| CN-1302544-A | Metribuzin-amide herbicide composition and preparation thereof | INST OF PLANT AND ENVIRONMENT (CN) | 2001-07-11 | — | — | CN | disclosed |
| WO-2001039749-A2 | FAST DISSOLVING COMPOSITION WITH PROLONGED SWEET TASTE | PANACEA BIOTEC LIMITED (IN) | 2001-06-07 | — | — | WO | disclosed |
| US-6221383-B1 | BLEND OF AT LEAST TWO POLYMERS, OR AT LEAST ONE POLYMER AND A SOLUBLE POLYVINYLPYRROLIDONE, IN COMBINATION WITH A DRUG PROVIDES A PRESSURE-SENSITIVE ADHESIVE COMPOSITION FOR A TRANSDERMAL DRUG DELIVERY SYSTEM | NOVEN PHARMACEUTICALS, INC. | 2001-04-24 | — | — | US | disclosed |
| EP-1087791-A1 | INHIBITION OF XENOREACTIVE ANTIBODIES | Baxter International Inc. (US) | 2001-04-04 | — | — | EP | disclosed |
| EP-1087791-A1 | INHIBITION OF XENOREACTIVE ANTIBODIES | Baxter International Inc. (US) | 2001-04-04 | — | — | EP | disclosed |
| US-6207389-B1 | PROTEIN FOR THE DIAGNOSIS, TREATMENT AND PREVENTION OF DIABETES | HRC RESEARCH AND DEVELOPMENT LIMITED PARTNERSHIP (CA) | 2001-03-27 | — | — | US | disclosed |
| WO-2001017568-A2 | BIOCONJUGATION IN VIVO TO PULMONARY OR BLOOD COMPONENTS | CONJUCHEM, INC. (CA) | 2001-03-15 | — | — | WO | disclosed |
| CN-1060912-C | Metribuzin and amide herbicide composition and preparation thereof | INST OF PLANT PROT AND ENVIRON (CN) | 2001-01-24 | — | — | CN | disclosed |
| WO-2000076480-A2 | PHARMACEUTICAL MATERIALS AND METHODS FOR THEIR PREPARATION AND USE | ELI LILLY AND COMPANY (US) | 2000-12-21 | — | — | WO | disclosed |
| WO-2000074661-A2 | SOLUBILITY ENHANCEMENT OF DRUGS IN TRANSDERMAL DRUG DELIVERY SYSTEMS AND METHODS OF USE | NOVEN PHARMACEUTICALS, INC. (US) | 2000-12-14 | — | — | WO | disclosed |
| US-6156514-A | PREPARING AGGREGATES WITH AMPLIFIED AMINO ACID SEQUENCE EXPRESSION; TRANSFORM TISSUE, CULTURE TISSUE, ISOLATE TISSUE EXPRESSING AMINO ACID SEQUENCES, TRANSFORM AND CULTURE TISSUE, ISOLATE TISSUE WHICH EXPRESSES AMINO ACID SEQUENCES | SUNOL MOLECULAR CORPORATION (US) | 2000-12-05 | — | — | US | disclosed |
| EP-1030659-A1 | (+)-EPHEDRINE AS A SYMPATHOMIMETIC DRUG | WARNER-LAMBERT COMPANY (US) | 2000-08-30 | — | — | EP | disclosed |
| EP-1021204-A2 | BIOADHESIVE COMPOSITIONS AND METHODS FOR TOPICAL ADMINISTRATION OF ACTIVE AGENTS | NOVEN PHARMACEUTICALS, INC. (US) | 2000-07-26 | — | — | EP | disclosed |
| WO-2000032821-A1 | METHODS FOR MAKING RECOMBINANT CELLS | SUNOL MOLECULAR CORPORATION (US) | 2000-06-08 | — | — | WO | disclosed |
| US-6024976-A | TRANSDERMAL DRUG DELIVERY WITH PRESSURE SENSITIVE ADHESIVE COMPOSITION OF POLYVINYLPYRROLIDONE WITH DRUG IN MULTILAYER PATCH | NOVEN PHARMACEUTICALS, INC. (US) | 2000-02-15 | — | — | US | disclosed |
| WO-1999052561-A1 | INHIBITION OF XENOREACTIVE ANTIBODIES | BAXTER INTERNATIONAL INC. (US) | 1999-10-21 | — | — | WO | disclosed |
| WO-1999052561-A1 | INHIBITION OF XENOREACTIVE ANTIBODIES | BAXTER INTERNATIONAL INC. (US) | 1999-10-21 | — | — | WO | disclosed |
| WO-1999025328-A1 | (+)-EPHEDRINE AS A SYMPATHOMIMETIC DRUG | WARNER-LAMBERT COMPANY (US) | 1999-05-27 | — | — | WO | disclosed |
| EP-0910410-A1 | TOPICAL COMPOSITION COMPRISING A COMBINATION OF ANTIHISTAMINIC COMPOUNDS WITH TERPENOID COMPOUNDS | Novartis Consumer Health S.A. (CH) | 1999-04-28 | — | — | EP | disclosed |
| WO-1999015210-A2 | BIOADHESIVE COMPOSITIONS AND METHODS FOR TOPICAL ADMINISTRATION OF ACTIVE AGENTS | NOVEN PHARMACEUTICALS, INC. (US) | 1999-04-01 | — | — | WO | disclosed |
| US-5883229-A | BCL-Y IS INVOLVED IN MEDIATING CELL DEATH OR SURVIVAL | COCENSYS, INC. (US) | 1999-03-16 | — | — | US | disclosed |
| US-5789201-A | CONTROLLING APOPTOSIS; MAMMALS | COCENSYS, INC. (US) | 1998-08-04 | — | — | US | disclosed |
| US-5763585-A | MODULATORS OF T-CELLS FOR IMMUNOLOGICAL DISORDERS | ANERGEN, INC. (US) | 1998-06-09 | — | — | US | disclosed |
| EP-0839191-A1 | AUTOREACTIVE PEPTIDES FROM HUMAN GLUTAMIC ACID-DECARBOXYLASE (GAD) | Roche Diagnostics GmbH (DE) | 1998-05-06 | — | — | EP | disclosed |
| EP-0833930-A2 | FUSED SOLUBLE MHC HETERODIMER:PEPTIDE COMPLEXES AND THEIR USES | ZymoGenetics, Inc. (US) | 1998-04-08 | — | — | EP | disclosed |
| US-5719197-A | DRUG DELIVERY | NOVEN PHARMACEUTICALS, INC. (US) | 1998-02-17 | — | — | US | disclosed |
| WO-1998001134-A1 | ORAL PHARMACEUTICAL COMBINATIONS OF ANTIHISTAMINIC COMPOUNDS AND TERPENOIDS | NOVARTIS CONSUMER HEALTH S.A. (CH) | 1998-01-15 | — | — | WO | disclosed |
| WO-1998000168-A1 | TOPICAL COMPOSITION COMPRISING A COMBINATION OF ANTIHISTAMINIC COMPOUNDS WITH TERPENOID COMPOUNDS | NOVARTIS CONSUMER HEALTH S.A. (CH) | 1998-01-08 | — | — | WO | disclosed |
| CN-1148465-A | Metribuzin and amide herbicide composition and preparation thereof | INST OF PLANT PROTECTION AND E (CN) | 1997-04-30 | — | — | CN | disclosed |
| EP-0759035-A1 | METHODS FOR CONTROLLING T LYMPHOCYTE MEDIATED IMMUNE RESPONSES | HSC Research and Development Limited Partnership (CA) | 1997-02-26 | — | — | EP | disclosed |
| WO-1997004085-A1 | AUTOREACTIVE PEPTIDES FROM HUMAN GLUTAMIC ACID-DECARBOXYLASE (GAD) | BOEHRINGER MANNHEIM GMBH (DE) | 1997-02-06 | — | — | WO | disclosed |
| WO-1996040084-A1 | COMPOSITIONS AND METHODS FOR USE OF PRESSURE SENSITIVE ADHESIVE TRANSDERMAL DEVICES CONTAINING A BIOADHESIVE HUMECTANT | NOVEN PHARMACEUTICALS, INC. (US) | 1996-12-19 | — | — | WO | disclosed |
| WO-1996040086-A2 | COMPOSITIONS AND METHODS FOR TOPICAL ADMINISTRATION OF PHARMACEUTICALLY ACTIVE AGENTS | NOVEN PHARMACEUTICALS, INC. (US) | 1996-12-19 | — | — | WO | disclosed |
| WO-1996040944-A2 | FUSED SOLUBLE MHC HETERODIMER:PEPTIDE COMPLEXES AND THEIR USES | ZYMOGENETICS, INC. (US) | 1996-12-19 | — | — | WO | disclosed |
| EP-0705111-A1 | AGENT WITH INFLUENCES HYPERACTIVE IMMUNOLOGICAL EFFECTOR CELLS | LESKOVAR, Peter (DE) | 1996-04-10 | — | — | EP | disclosed |
| WO-1995029936-A1 | METHODS FOR CONTROLLING T LYMPHOCYTE MEDIATED IMMUNE RESPONSES | HSC RESEARCH AND DEVELOPMENT LIMITED PARTNERSHIP (CA) | 1995-11-09 | — | — | WO | disclosed |
| US-5446070-A | Flexible, finite, bioadhesive, therapeutical agent in solid form | NOVER PHARMACEUTICALS, INC. (US) | 1995-08-29 | — | — | US | disclosed |
| EP-0665289-A2 | Peptides from GAD65, provoking autoimmune reactions | Roche Diagnostics GmbH (DE) | 1995-08-02 | — | — | EP | disclosed |
| WO-1995000175-A1 | AGENT WITH INFLUENCES HYPERACTIVE IMMUNOLOGICAL EFFECTOR CELLS | LESKOVAR PETER (DE) | 1995-01-05 | — | — | WO | disclosed |
| US-5276044-A | For topical application having enhanced effectiveness and decreased irritancy | ALLERGAN, INC. (US) | 1994-01-04 | — | — | US | disclosed |
| EP-0537143-A1 | COMPOSITION AND PROCESS FOR TREATING WATER CONTAINING METAL IONS AND ORGANIC AND/OR INORGANIC IMPURITIES. | STRATEN GUENTER (DE) | 1993-04-21 | — | — | EP | disclosed |
| EP-0537143-A1 | COMPOSITION AND PROCESS FOR TREATING WATER CONTAINING METAL IONS AND ORGANIC AND/OR INORGANIC IMPURITIES. | STRATEN GUENTER (DE) | 1993-04-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (26 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040141922-A1 | Diagnostic/therapeutic agents | BID, FUS, FABP1 | KDM1A 4361/4885CYP2D6 4840/4885CYP1A2 4874/4885 |
| US-20100009970-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF VIRAL DISEASES | HTR1A, HTR3B, HTR3A | KDM1A 491/4885CYP2D6 650/4885CYP1A2 588/4885 |
| US-20070010502-A1 | Methods and reagents for the treatment of immunoinflammatory disorders | IL5, TPMT, TSLP | KDM1A 3260/4885CYP2D6 981/4885CYP1A2 1083/4885 |
| US-20040141944-A1 | Inhibition of xenoreactive antibodies | LY96, CD47, HLA-A | KDM1A 2177/4885CYP2D6 2168/4885CYP1A2 2145/4885 |
| US-20050002865-A1 | Diagnostic/therapeutic agents | FUS, HNRNPF, HNRNPR | KDM1A 4843/4885CYP2D6 4709/4885CYP1A2 4806/4885 |
| US-20070225217-A1 | Methods, compositions, and kits for the treatment of medical conditions | TNF, PYGM, IL6 | KDM1A 4174/4885CYP2D6 3055/4885CYP1A2 2802/4885 |
| US-20220313656-A1 | NEW CLASS OF ANTIBIOTICS HAVING LOW MIC-VALUES TOWARDS DIFFERENT STRAINS OF BACTERIA | NR4A1, NR4A3, NR1H4 | KDM1A 4059/4885CYP2D6 201/4885CYP1A2 197/4885 |
| US-20080124396-A1 | Inhibition of Xenoreactive Antibodies | LY96, HLA-A, CD47 | KDM1A 1843/4885CYP2D6 1854/4885CYP1A2 1804/4885 |
| US-20080161324-A1 | Compositions and methods for treatment of viral diseases | HAVCR2, EIF2AK2, RNASE1 | KDM1A 1320/4885CYP2D6 1538/4885CYP1A2 1154/4885 |
| US-10869933-B2 | Oligomer-phenothiazine conjugates | HTT, MAPT, SLCO1B3 | KDM1A 4268/4885CYP2D6 283/4885CYP1A2 377/4885 |
| US-20260134941-A1 | BIOINFORMATIC PROCESSES FOR DETERMINATION OF PEPTIDE BINDING | MICA, HLA-DRB1, CD74 | KDM1A 4790/4885CYP2D6 3040/4885CYP1A2 4831/4885 |
| US-20040156859-A1 | GP-41 peptides, BBB peptides, anticancer agents, antihistamines, bronchodilators, hypotensive agents, antiangina agents, opioids, analgesics, antidepressants, and hypothyroid agents reactive with amino, hydroxyl or thiol groups | OGFR, HDGF, SERPINA6 | KDM1A 2836/4885CYP2D6 1094/4885CYP1A2 2699/4885 |
| US-20070208134-A1 | Anti-scarring drug combinations and use thereof | MMP1, COL2A1, COL1A1 | KDM1A 1259/4885CYP2D6 3701/4885CYP1A2 1939/4885 |
| US-20050192261-A1 | Methods and reagents for the treatment of immunoinflammatory disorders | IL5, CMA1, CCL11 | KDM1A 1594/4885CYP2D6 835/4885CYP1A2 668/4885 |
| US-20040224876-A1 | Combination therapy for the treatment of immunoinflammatory disorders | HLA-DRB1, TSLP, SERPINA6 | KDM1A 4496/4885CYP2D6 501/4885CYP1A2 773/4885 |
| US-20070196421-A1 | Soft tissue implants and drug combination compositions, and use thereof | COL2A1, MMP1, FN1 | KDM1A 1466/4885CYP2D6 597/4885CYP1A2 869/4885 |
| US-20070299043-A1 | Anti-scarring drug combinations and use thereof | MMP1, COL2A1, COL1A1 | KDM1A 1259/4885CYP2D6 3701/4885CYP1A2 1939/4885 |
| US-20100120768-A1 | METHODS, KITS, AND COMPOSITIONS FOR GENERATING NEW HAIR FOLLICLES AND GROWING HAIR | NGF, HDGF, SHH | KDM1A 2646/4885CYP2D6 4169/4885CYP1A2 3033/4885 |
| US-20200038517-A1 | OLIGOMER-PHENOTHIAZINE CONJUGATES | HTT, MAPT, SLCO1B3 | KDM1A 4268/4885CYP2D6 283/4885CYP1A2 377/4885 |
| US-20120156228-A1 | Methods, Kits, and Compositions for Generating New Hair Follicles and Growing Hair | NGF, HDGF, SHH | KDM1A 2646/4885CYP2D6 4169/4885CYP1A2 3033/4885 |
| US-20120046279-A1 | Oligomer-Phenothiazine Conjugates | HTT, MAPT, SLCO1B3 | KDM1A 4268/4885CYP2D6 283/4885CYP1A2 377/4885 |
| US-20100081713-A1 | COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS | IFNG, IL5, HAVCR2 | KDM1A 1579/4885CYP2D6 4016/4885CYP1A2 2396/4885 |
| US-20120058979-A1 | METHODS AND REAGENTS FOR THE TREATMENT OF IMMUNOINFLAMMATORY DISORDERS | IL5, TPMT, TSLP | KDM1A 3260/4885CYP2D6 981/4885CYP1A2 1083/4885 |
| US-20050032900-A1 | Ibuprofen salt emulsifiers and cream formulations containing same | ALOX12, NAPEPLD, ACMSD | KDM1A 2080/4885CYP2D6 229/4885CYP1A2 312/4885 |
| US-20020102215-A1 | Diagnostic/therapeutic agents | BID, FUS, FABP1 | KDM1A 4293/4885CYP2D6 4855/4885CYP1A2 4880/4885 |
| US-20050119160-A1 | Methods and reagents for the treatment of immunoinflammatory disorders | IL5, TPMT, TSLP | KDM1A 3260/4885CYP2D6 981/4885CYP1A2 1083/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.